ID   2004
AC   CVCL_U759
DR   Cosmic; 802248
DR   GEO; GSM3145595
DR   GEO; GSM3145685
DR   PharmacoDB; 2004_6_2019
DR   Wikidata; Q54583040
RX   PubMed=9671307;
RX   PubMed=10397258;
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Heterozygous (PubMed=9671307).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C8715; Rhabdoid tumor of the kidney
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 13
//
RX   PubMed=10397258;
RA   Rousseau-Merck, Marie-Francoise
RA   Versteege, Isabella
RA   Legrand, Isabelle
RA   Couturier, Jerome
RA   Mairal, Aline
RA   Delattre, Olivier
RA   Aurias, Alain
RT   "hSNF5/INI1 inactivation is mainly associated with homozygous
RT   deletions and mitotic recombinations in rhabdoid tumors.";
RL   Cancer Res. 59:3152-3156(1999).
//
RX   PubMed=9671307; DOI=10.1038/28212;
RA   Versteege, Isabella
RA   Sevenet, Nicolas
RA   Lange, Julian
RA   Rousseau-Merck, Marie-Francoise
RA   Ambros, Peter F.
RA   Handgretinger, Rupert
RA   Aurias, Alain
RA   Delattre, Olivier
RT   "Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer.";
RL   Nature 394:203-206(1998).
//